Rickets, Hypophosphatemic: Clinical Trials

8 trials for Rickets, Hypophosphatemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 recruiting. 8 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 7, Recruiting 1
Phase 15Completed 4, Recruiting 1

Follow Rickets, Hypophosphatemic: new trials by email Literature Review of Rickets, Hypophosphatemic trials Research Report on Rickets, Hypophosphatemic

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
KK8123 - X-linked Hypophosphatemia
Phase 1 / Phase 2RecruitingKyowa Kirin Co., Ltd.392024-10-092026-11-06
Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
Burosumab - X-linked Hypophosphatemia (XLH)
Phase 1 / Phase 2CompletedKyowa Kirin Pharmaceutical Development Ltd162020-02-262024-11-07
Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Burosumab - X-Linked Hypophosphatemia
Phase 2CompletedKyowa Kirin, Inc.132016-05-052024-05-06
Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
KRN23 - X-Linked Hypophosphatemia
Phase 2CompletedKyowa Kirin, Inc.202015-01-302024-05-06
Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
burosumab - X-linked Hypophosphatemia
Phase 2CompletedKyowa Kirin, Inc.522014-07-022024-05-06
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.232012-02-012024-06-18
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.292011-04-012024-06-18
Growth Hormone Treatment in Children With Hypophosphatemic Rickets
norditropine simplex - X Linked Hypophosphatemic Rickets
Phase 1 / Phase 2CompletedBicetre Hospital192006-01-012016-03-28

Narrower conditions

Familial Hypophosphatemic Rickets (8)  ·  Bone Diseases (1)  ·  Hypophosphatemia (1)  ·  Kidney Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Rare Diseases (1)

Broader conditions

Avitaminosis (8)  ·  Bone Diseases, Metabolic (8)  ·  Calcium Metabolism Disorders (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8)  ·  Deficiency Diseases (8)  ·  Female Urogenital Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Genetic Diseases, Inborn (8)  ·  Hypophosphatemia, Familial (8)  ·  Male Urogenital Diseases (8)  ·  Malnutrition (8)  ·  Metabolism, Inborn Errors (8)  ·  Metal Metabolism, Inborn Errors (8)  ·  Nutrition Disorders (8)  ·  Nutritional and Metabolic Diseases (8)

Interventions

burosumab (6)  ·  Growth Hormone (1)

Sponsors

Kyowa Kirin Co., Ltd. (3)  ·  Kyowa Kirin, Inc. (3)  ·  Bicetre Hospital (1)  ·  Kyowa Kirin Pharmaceutical Development Ltd (1)

Countries

United States (6)  ·  Canada (3)  ·  France (3)  ·  Spain (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

Amy Zhang, PhD (2)

Results publications

PMID 25919461, PMID 32721016, PMID 39151033, PMID 26073451, PMID 28822957, PMID 29791829, PMID 30638856, PMID 34636899, PMID 36072994, PMID 42044650